Rituximab in Treating Patients With Waldenstrom’s Macroglobulinemia
Condition(s):LymphomaLast Updated:August 3, 2020Completed
Hide Studies Not Open or Pending
Condition(s):LymphomaLast Updated:August 3, 2020Completed
Condition(s):Waldenström MacroglobulinemiaLast Updated:June 10, 2021No longer available
Condition(s):LymphomaLast Updated:May 17, 2013Completed
Condition(s):LymphomaLast Updated:March 6, 2015Withdrawn
Condition(s):LymphomaLast Updated:December 18, 2013Unknown status
Condition(s):LymphomaLast Updated:March 6, 2015Completed
Condition(s):B Cell Non-Hodgkin’s Lymphoma; Chronic Lymphocytic Leukemia; Waldenstrom MacroglobulinemiaLast Updated:November 8, 2019Completed
Condition(s):LymphomaLast Updated:January 8, 2013Withdrawn
Condition(s):LymphomaLast Updated:January 8, 2013Terminated
Condition(s):LymphomaLast Updated:June 29, 2023Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.